baquiloprim

Modify Date: 2024-01-04 19:37:32

baquiloprim structure	Common Name	baquiloprim
	CAS Number	102280-35-3	Molecular Weight	308.381
	Density	1.3±0.1 g/cm3	Boiling Point	567.9±60.0 °C at 760 mmHg
	Molecular Formula	C₁₇H₂₀N₆	Melting Point	N/A
	MSDS	Chinese USA	Flash Point	297.2±32.9 °C
	Symbol	GHS07	Signal Word	Warning

Use of baquiloprim

Baquiloprim, an antibiotic, is a selective inhibitor of bacterial dihydrofolate reductases. Baquiloprim possesses in vitro bacteriostatic activity against both Gram-negative and Gram-positive bacteria[1][2].

Name	baquiloprim
Synonym	More Synonyms

Description	Baquiloprim, an antibiotic, is a selective inhibitor of bacterial dihydrofolate reductases. Baquiloprim possesses in vitro bacteriostatic activity against both Gram-negative and Gram-positive bacteria[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial
References	[1]. Lewicki J, et, al. Oral bioavailability and pharmacokinetics of baquiloprim in dwarf goats. Res Vet Sci. 1995 May;58(3):268-71. [2]. White DG, et, al. Comparison of danofloxacin with baquiloprim/sulphadimidine for the treatment of experimentally induced Escherichia coli diarrhoea in calves. Vet Rec. 1998 Sep 5;143(10):273-6.

Description

Related Catalog

Research Areas >> Infection

Signaling Pathways >> Anti-infection >> Bacterial

References

[1]. Lewicki J, et, al. Oral bioavailability and pharmacokinetics of baquiloprim in dwarf goats. Res Vet Sci. 1995 May;58(3):268-71.

[2]. White DG, et, al. Comparison of danofloxacin with baquiloprim/sulphadimidine for the treatment of experimentally induced Escherichia coli diarrhoea in calves. Vet Rec. 1998 Sep 5;143(10):273-6.

Density	1.3±0.1 g/cm3
Boiling Point	567.9±60.0 °C at 760 mmHg
Molecular Formula	C₁₇H₂₀N₆
Molecular Weight	308.381
Flash Point	297.2±32.9 °C
Exact Mass	308.174957
PSA	93.95000
LogP	2.32
Vapour Pressure	0.0±1.6 mmHg at 25°C
Index of Refraction	1.719

baquiloprim MSDS(Chinese)

Symbol	GHS07
Signal Word	Warning
Hazard Statements	H302-H315-H319-H335
Precautionary Statements	P261-P305 + P351 + P338
Hazard Codes	Xn
Risk Phrases	22-36/37/38
Safety Phrases	26
RIDADR	NONH for all modes of transport
RTECS	UV8142576

Eimeria alabamensis coccidiosis in grazing calves: control by a long-acting baquiloprim/sulphadimidine bolus.

Appl. Parasitol. 37(3) , 168-76, (1996)

The excretion of Eimeria oocysts, the faecal dry matter and the weight gain of three groups of 12 calves, were compared during their first 20 days of grazing on a pasture known to have been contaminat...

Oral bioavailability and pharmacokinetics of baquiloprim in dwarf goats.

Res. Vet. Sci. 58(3) , 268-71, (1995)

The pharmacokinetics of baquiloprim at a dose of 8 mg kg-1 bodyweight were determined after its intravenous and intra-ruminal administration to seven healthy female dwarf goats. After intravenous inje...

Prevention of Eimeria alabamensis coccidiosis by a long-acting baquiloprim/sulphadimidine bolus.

Vet. Parasitol. 74(2-4) , 143-52, (1998)

Twelve calves aged 6-10 months, and 12 calves aged 10-16 months were turned out onto a permanent pasture known to have been contaminated with oocysts of Eimeria alabamensis during the previous year. T...

5-{[8-(Dimethylamino)-7-methyl-5-quinolinyl]methyl}-2,4-pyrimidinediamine

baquiloprim

2,4-Pyrimidinediamine, 5-[[8-(dimethylamino)-7-methyl-5-quinolinyl]methyl]-

5-((2,4-Diamino-5-pyrimidinyl)methyl)-8-(dimethylamino)-7-methylquinoline